Today: 28 March 2026
Subscribe
Browse Category

NASDAQ:CATX 30 January 2026

Perspective Therapeutics stock (CATX) steadies before the open after 66% jump — what investors watch next

Perspective Therapeutics stock (CATX) steadies before the open after 66% jump — what investors watch next

Perspective Therapeutics shares slipped 0.8% to $4.22 in early premarket trading Friday after surging 66.4% the previous day, with volume topping 69 million shares. The stock’s sharp moves follow recent clinical updates and filings, but no new disclosures drove Thursday’s spike. Traders are watching for further swings as the regular session opens. Next earnings report is scheduled for March 26.
30 January 2026
·

Stock Market Today

  • Analysts Back Barratt Redrow as Top FTSE 100 Buy in April
    March 28, 2026, 5:20 AM EDT. Barratt Redrow, the UK's largest housebuilder by volume, has seen its FTSE 100 stock fall 38% over the past year amid sector-wide challenges like excess inventory, rising costs, and high interest rates. Despite CEO turnover and profit warnings, analysts project a robust 76% price gain, citing Barratt Redrow's significant cost advantage through scale, accounting for 10% of UK homebuilding. The sector's cyclical downturn and macroeconomic pressures, including inflation linked to the Iran conflict, underpin near-term risks. However, the structural housing shortage and Barratt Redrow's ability to negotiate supplier costs are seen as key factors for long-term recovery. With the highest analyst price target gap in the FTSE 100, it emerges as a favored stock for potential gains if broader economic conditions improve.
Go toTop